The use of psychometric methods for the diagnosis of anxiety and depressive disorders in patients with a general somatic profile

Abstract

Aim. To identify and compare the level of anxiety and depression in therapeutic patients with somatic pathology, establish the structure of the gender distribution of anxiety and depressive disorders.

Methods. The study involved 126 people: 74 (58.73%) women and 52 (41.27%) men aged 21–59 years. 59 patients had diseases of the respiratory system (chronic bronchitis in the acute stage with an asthmatic component), 67 patients with cardiovascular diseases (40 subjects with coronary heart disease, 27 subjects with arterial hypertension). In 11 patients with coronary artery disease and 13 patients with hypertension, type I thyrotoxicosis was diagnosed. Clinical psychopathological, psychometric, psychological and statistical methods were used in the study. Psychometric tests were used: the Depression Scale of the Center for Epidemiological Research; Hospital Anxiety and Depression Scale and Taylor Anxiety Disorder Scale adapted by T.A. Nemchinova and V.G. Norakidze, adapted standardized multivariate questionnaire for personality research.

Results. According to the severity of anxiety and depressive disorders, patients were divided into the groups: group 1 with severe level, group 2 with a moderate (subclinical) level, and group 3 with mild (not exceeding the norm) anxiety and depressive disorders. Severe and moderate disorders are most characteristic for the pathology of cardiovascular system. In coronary artery disease and arterial hypertension, abnormal (severe and moderate) anxiety and depressive disorders were observed in 24/29 (82.76%) and 20/22 (90.9%) patients, respectively. In patients with abnormal anxiety and depressive disorders, the number of women prevailed over men in the subgroup with hypertension (80% versus 20%, p=0.025) as well as in combination of hypertension with type 1 thyrotoxicosis (85.7% versus 14.3%, р=0.029).

Conclusion. In patients, severe and moderate anxiety and depressive disorders are associated with the development of the pathology of cardiovascular system: coronary heart disease and arterial hypertension.

Keywords

anxiety and depressive disorders / somatic pathology / comorbidity / gender differences

References

[1] WHO. Fact sheet N369. https://www.who.int/ru/news-room/fact-sheets/detail/depression (access date: 14.12.2018) (In Russ.)

[2] ВОЗ. Информационный бюллетень №369. https://www.who.int/ru/news-room/fact-sheets/detail/depression (дата обращения: 14.12.2018).

[3] Neznanov N.G., Mazo G.E., Rukavishnikov G.V., Kibi­tov A.O. Depression as a predictor of somatic diseases: pathophysiological background and genetic risk. Uspekhi fiziologicheskih nauk. 2017; 48 (4): 29–39. (In Russ.)

[4] Незнанов Н.Г., Мазо Г.Э., Рукавишников Г.В., Кибитов А.О. Депрессия как предиктор соматических заболеваний: патофизиологические предпосылки и генетический риск. Успехи физиол. наук. 2017; 48 (4): 29–39.

[5] Andryushchenko A.V. The prevalence and structure of mental disorders in general medicine. Psihicheskie rasstroystva v obshchey meditsine. 2011; (1): 14–27. (In Russ.)

[6] Андрющенко А.В. Распространённость и структура психических расстройств в общей медицине. Психические расстройства в общей медицине. 2011; (1): 14–27.

[7] Starostina E.G., Volodina M.N., Starostin I.V., Bobrov A.E. Depression and diabetes as comorbid diseases. RMZh. 2017; 25 (22): 1613–1620. (In Russ.)

[8] Старостина Е.Г., Володина М.Н., Старостин И.В., Бобров А.Е. Депрессия и сахарный диабет как коморбидные заболевания. РМЖ. 2017; 25 (22): 1613–1620.

[9] Smulevich A.B., Dubnitskaya E.B., Voronova E.I. To the problem of recognition of psychosomatic disorders in ge­neral medical practice. Psihicheskie rasstroystva v obshchey meditsine. 2017; (3–4): 4–10. (In Russ.)

[10] Смулевич А.Б., Дубницкая Э.Б., Воронова Е.И. К проблеме распознавания психосоматических расстройств в общемедицинской практике. Психические расстройства в общей медицине. 2017; (3–4): 4–10.

[11] Smulevich A.B. Depressii pri psikhi­cheskikh i somaticheskikh zabolevaniyakh. (Depression in mental and somatic diseases.) 4th ed. Moscow: MIA. 2005; 64 p. (In Russ.)

[12] Смулевич А.Б. Депрессии при психических и соматических заболеваниях. 4-е изд., перераб. и доп. М.: МИА. 2005; 64 с.

[13] Romasenko L.V. Depression and cardiovascular diseases. Nevrologiya, nejropsihiatriya, psihosomatika. 2009; (3–4): 8. (In Russ.)

[14] Ромасенко Л.В. Депрессия и сердечно-сосудистые заболевания. Неврология, нейропсихиатрия, психосоматика. 2009; (3–4): 8. DOI: 10.14412/2074-2711-2009-48.

[15] Omel'chenko V.P., Demidova A.A. Medicinskaya informatika. Rukovodstvo k prakticheskim zanjatijam: uchebnoe posobie. Glava 10. Statisticheskaja obrabotka rezul'tatov mediko-biologicheskogo issledovanija. (Medical informatics. A guide to practical exercises: a tutorial. Chapter 10. Statistical processing of the results of medical and biological research.) Moscow: GEOTAR-Media. 2017; 324–356. (In Russ.)

[16] Омельченко В.П., Демидова А.А. Медицинская информатика. Руководство к практическим занятиям: учебное пособие. Глава 10. Статистическая обработка результатов медико-биологического исследования. М: ГЭОТАР-Медиа. 2017; 324–356.

RIGHTS & PERMISSIONS

Dubatova I.V., Voyakina V.G., Lepyavka S.V., Safronenko A.V., Demidov I.A.